Latest Market Access News

Orange Minerals reports exceptional silver grades at its Lennon’s Find project in WA and advances its strategic acquisition in Ghana, while expanding its investor reach with a US market listing.

Energy Metals Limited reports promising high-grade uranium intersections from recent drilling at its Ngalia Regional Project, supported by a robust cash position and a strengthening uranium market.

Lakes Blue Energy marked a pivotal quarter with its ASX reinstatement, a $5.8 million capital raise, and completion of the Wombat-5 well, setting the stage for imminent production testing and resource upgrades.

4DMedical Limited has secured FDA clearance and immediate Medicare reimbursement for its groundbreaking CT – VQ™ lung imaging technology, accelerating commercial adoption across the US, Brazil, and Australia.

D3 Energy has secured formal acceptance of its Production Right Application for the ER315 permit in South Africa, marking a pivotal step toward production. The company also broadened its portfolio with new helium and hydrogen permits in Australia and began trading on the US OTCQX market.

Cleo Diagnostics has successfully completed Stage 1 of the Medical Device Single Audit Program, marking a significant step toward FDA submission and global commercialisation of its ovarian cancer test.

Terragen Holdings expands its probiotic product range into beef and lamb feedlots, secures key international approvals, and progresses large-scale trials while maintaining a $3 million cash reserve.

Alliance Nickel’s September 2025 quarterly report highlights a robust Definitive Feasibility Study for its NiWest Nickel-Cobalt Project, alongside ongoing strategic partnership talks and solid financial footing.

Island Pharmaceuticals has completed its acquisition of the broad-spectrum antiviral Galidesivir and is progressing regulatory discussions with the FDA to fast-track approval using the Animal Rule, backed by compelling preclinical data.

Li-S Energy has marked a milestone with the production of Australia’s first lithium metal foils and expanded its footprint in the global defense sector, supported by new manufacturing capabilities and strategic partnerships.

ImpediMed Limited reported a record A$3.6 million quarterly revenue and expanded its US hospital footprint with over 600 SOZO units installed. The launch of SOZO Pro targets new heart failure markets, while reimbursement coverage accelerates across US states.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for chronic wound treatment and advances regulatory filings for its TR Pro+® product, while gearing up for a major commercial rollout in early 2026.